Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-04

Clinical Trial Update: Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing standard chemotherapy regimens with versus without ixabepilone (Ixempra) given before surgery in early-stage breast cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ixabepilone (Ixempra) (ixabepilone)
  • Standard chemotherapy regimens (unspecified)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-04-04